A Message From The ESCRS President


Rudy Nuijts
Published: Saturday, March 21, 2020

Dear Colleagues
Today our ESCRS newsletter focuses on France, where the medical community is coping with a substantial outbreak of the coronavirus, especially in the northeast of the country (le Grand-Est, Alsace), on the border with Italy and more recently in Paris. ESCRS past president Béatrice Cochener-Lamard has shared with us some of the protocols and guidelines put in place in her country.
We are committed to keeping you well informed in the difficult times ahead. The ESCRS EuroTimes home page www.eurotimes.org has been deployed as an information repository on COVID-19 for ophthalmologists. Here you will find a library of documents, journal papers and correspondence from our colleagues around the world.
I am very gratified by the messages I have received since we began this newsletter last weekend, from colleagues in Italy thanking us for our support, colleagues in Egypt reaching out with their own stories and Prof Lai, from Hong Kong who published one of the first peer-reviewed papers on controlling this infection offering his support and advice.
Please stay safe and well.


Prof. dr Rudy MMA Nuijts
ESCRS President
READ THE FULL NEWSLETTER HERE
http://createsend.com/t/r-555E02997C069E7A2540EF23F30FEDED
Tags: covid-19
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.